CAS 2108968-42-7

P2Y14 antagonist prodrug 7J hydrochloride

CAS: 2108968-42-7

7J is a prodrug that is converted to 7-deacetylgolvatinib in vivo. It is a potent antitumor agent that belongs to the class of pharmaceutical drugs. 7J has been shown to have potent antitumor activity against various types of cancer cells, including breast, prostate, lung, and bladder cancer cells. The mechanism of action for 7J appears to be related to its ability to inhibit tumor cell proliferation and induce apoptosis. This drug also inhibits the growth of bacteria by binding to bacterial DNA gyrase and topoisomerase IV enzymes. The mechanism of action for this drug is similar to other kinase inhibitors such as golvatinib or imatinib.

Formula: C₃₃H₃₁F₃N₂O₃·HCl

Purity: Min. 95%

Molecular weight: 597.07 g/mol

Ref: 3D-QCC30819